Preprint · February 20, 2026
BACKGROUND AND AIMS: The glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide has demonstrated efficacy for the secondary prevention of cardiovascular disease among patients with overweight/obesity without diabetes mellitus. However, the compara ...
Full textLink to itemCite
Journal articleJCO Oncol Pract · January 2026
PURPOSE: Many cancer survivors consume alcohol above recommended limits, increasing their risk of recurrence, second cancers, and cancer-related mortality. Alcohol screening, brief intervention, and referral to treatment (SBIRT) is a guideline-recommended ...
Full textLink to itemCite
Journal articleGerontologist · October 22, 2025
BACKGROUND AND OBJECTIVES: Person-centered "home time" measures track time spent in health care versus home using claims data. These measures can indicate patient preferences, quality of care, or quality of life. However, for people living with dementia, t ...
Full textLink to itemCite
ConferenceInnovation in Aging · December 31, 2024
AbstractEstimates of patient care costs often overlook the economic value of unpaid caregiving. This study aims to quantify the economic value of unpaid caregiving by rural FCGs. Using data from a multi-site ...
Full textCite
Journal articleJ Pain Symptom Manage · December 2024
CONTEXT: Family caregivers (FCGs) play a crucial role in care for people with serious illness, yet unpaid care is often overlooked in estimates of care recipient (CR) care costs. OBJECTIVES: This study quantifies the economic value of unpaid caregiving by ...
Full textLink to itemCite